SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City

22 Pages Posted: 11 May 2020

See all articles by Linus Wilson

Linus Wilson

University of Louisiana at Lafayette - College of Business Administration

Date Written: May 1, 2020

Abstract

The SARS-CoV-2, COVID-19, infection fatality rate (IFR) has been hard to accurately estimate. It is a key parameter for disease modeling and policy decisions. Asymptomatic spread and limited testing have understated infections in hard to predict ways across jurisdictions. We survey serology, antibody, studies of the COVID-19 infection to find official cases are understated by an average of 25-to-1. Further, we analyze the deaths and infections in New York City to estimate an overall IFR for the United States of 0.863 percent.

Note: Funding: We have received no funding to write this study.

Conflict of Interest: We have no conflicts of interest.

Keywords: antibody, CFR, COVID-19, death rates, IFR, New York City, SARS-CoV-2, serology, seroprevalance

JEL Classification: G22, I1, I18, J31, J65, K32

Suggested Citation

Wilson, Linus, SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City (May 1, 2020). Available at SSRN: https://ssrn.com/abstract=3590771 or http://dx.doi.org/10.2139/ssrn.3590771

Linus Wilson (Contact Author)

University of Louisiana at Lafayette - College of Business Administration ( email )

Department of Economics & Finance
214 Hebrard Blvd., Room 326
Lafayette, LA 70504-0200
United States
(337) 482-6209 (Phone)
(337) 482-6675 (Fax)

HOME PAGE: http://www.linuswilson.com

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
2,571
Abstract Views
13,366
rank
5,309
PlumX Metrics